Bone Biologics Corporation (BBLG) Total liabilities 2016–2020
Bone Biologics Corporation (BBLG) total liabilities at each fiscal year-end, per SEC filings.
$13.7MFY2020 · since FY2016: $9.1M → $13.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $13.7M | +15.1% |
| FY2019 | $11.9M | — |
| FY2016 | $9.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLG financial trends
BBLG RevenueBBLG Net incomeBBLG Net marginBBLG Gross profitBBLG Gross marginBBLG Operating incomeBBLG Operating marginBBLG Operating cash flowBBLG Free cash flowBBLG Capital expendituresBBLG Return on equityBBLG Stock buybacksBBLG Dividends paidBBLG Total assetsBBLG Shareholders’ equityBBLG overview →